A pharmaceutical factory in Taiwan that produces hydrochloroquine explodes. This is the 2nd largest manufacturer of hydrochloroquine in the world. #BREAKING#Taiwan's hydrochloroquine pharmaceutical factory has a big explosion, sensitive time
by GloomyMention This ticker symbol is under the radar, which Cathie Wood is purchasing over the last 3 months without a single sell. During the last week, she bought daily.
NEW — US warns that Turkey has stopped paying an outstanding debt of $2.3bn to American pharmaceutical companies. • They can stop selling drugs to Turkey • The debt increased
by: Ethan Huff (Natural News) China’s state-run media is lamenting the fact that increasingly more Chinese people are rejecting flu shots, and presumably the upcoming Wuhan coronavirus (COVID-19) vaccine, due to China’s
by: Ethan Huff (Natural News) President Donald Trump has signed an executive order (EO) to bring the production of pharmaceuticals and medical supplies back to the United States, and out of communist
www.caixinglobal.com/2020-05-15/kangmei-pharmaceutical-fined-84600-for-126-billion-fraud-101554230.html Kangmei Pharmaceutical Co. Ltd., the Chinese drugmaker marred by a financial fraud scandal, was fined 600,000 yuan ($84,600) by top securities regulators for inflating revenues and fabricating bank deposits.
by bgny The Trump administrations war against big pharma continues. Glenmark Pharmaceuticals Inc., USA was charged for conspiring to fix prices for generic drugs, the Department of Justice announced today.
The business of vaccines is soon to become a major source of profits for the world’s largest pharmaceutical corporations. A press release (Business Wire, January 21st 2016) published by marketwatch.com says that Technavio, one
by Sabremesh All clinical trials of pharmaceutical products should be pre-registered, and the results should always be released. The prevalence of deliberate non-disclosure means that data which shows adverse side-effects is
via RT: The US Department of Justice has reached a settlement that would allow Bayer AG’s $66 billion takeover of Monsanto Co, requiring the German company to sell $9 billion